Developmental and reproductive toxicology studies in nonhuman primates

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 86, Issue 6, 2009, Pages 446-462

  Chellman, Gary J ^a   Bussiere, Jeanine L ^b   Makori, Norbert ^c   Martin, Pauline L ^d   Ooshima, Yojiro ^c   Weinbauer, Gerhard F ^e  

^a CHARLES RIVER LABORATORIES   (United States)

^b AMGEN INC   (United States)

^c SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

^d CENTOCOR INC   (United States)

^e Developmental and Reproductive Toxicology   (Germany)

Author keywords

Cynomolgus; Embryo fetal development; Female reproduction; Juvenile; Male reproduction; Nonhuman primate; Pre postnatal development; Reproductive toxicology

Indexed keywords

MONOCLONAL ANTIBODY;

EMBRYOTOXICITY; FETUS DEVELOPMENT; GENITAL SYSTEM; GRIP STRENGTH; MATING; MOTHER CHILD RELATION; NONHUMAN; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PRIMATE; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; REVIEW; SPERMATOGENESIS; TERATOGENICITY; TESTIS SIZE; TOXICOKINETICS; TOXICOLOGY; UMBILICAL CORD BLOOD;

ANIMALS; ANIMALS, LABORATORY; CALLITHRIX; EMBRYONIC DEVELOPMENT; FEMALE; FETAL DEVELOPMENT; HAPLORHINI; MACACA FASCICULARIS; MACACA MULATTA; MALE; PHARMACEUTICAL PREPARATIONS; RABBITS; RATS; REPRODUCTION; SPECIES SPECIFICITY; TOXICITY TESTS;

ORYCTOLAGUS CUNICULUS; PRIMATES; RODENTIA;

EID: 73649114893     PISSN: 15429733     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrb.20216     Document Type: Review

References (81)

1. Amann RP. 2008. The cycle of the seminiferous epithelium in humans: a need to revisit? J Androl 29:469-487.
2. Amann RP, Johnson L, Thompson Jr DL, Pickett BW. 1976. Daily spermatozoal production, epididymal spermatozoal reserves and transit time of spermatozoa through the epididymis of the rhesus monkey. Biol Reprod 15:586-592.
3. Aslam H, Rosiepen G, Krishnamurthy H, ArslanM, Clemen G, Nieschlag E, Weinbauer GF. 1999. The cycle duration of the seminiferous epithelium remains unaltered during GnRH antagonist-induced testicular involution in rats and monkeys. J Endocrinol 161:281-288.
4. Atkinson LE, Hotchkiss J, Fritz GR, Surve AH, Neill JD, Knobil E. 1975. Circulating levels of steroids and chorionic gonadotropin during pregnancy in the rhesus monkey, with special attention to the rescue of the corpus luteum in early pregnancy. Biol Reprod 12:335-345.
5. Beck MJ, Padgett EL, Bowman CJ, Wilson DT, Kaufman LE, Varsho BJ, Stump DS, Nemec MD, Holson JF. 2006. Nonclinical juvenile toxicity testing. In: Hood RD, editor. Developmental and reproductive toxicology. Boca Raton: CRC Press. p 263-267.
6. Boothe R, Sackett F. 1975. Perception and learning in infant rhesus monkeys. In: Bourne G, editor. The rhesus monkey. New York: Academic Press. p 343-363.
7. Buckley LA, Benson K, Davis-Bruno K, Dempster M, Finch GL, Harlow P, Haggerty HG, Hart T, Kinter L, Leighton JK, McNulty J, Roskos L, Saber H, Stauber A, Tabrizi M. 2008. Nonclinical aspects of biopharmaceutical development: discussion of case studies at a PhRMA-FDA workshop. Int J Toxicol 27:303-312.
8. Buse E. 2005. Development of the immune system in the cynomolgus monkey: the appropriate model in human targeted toxicology? J Immunotoxicol 2:211-216.
9. Buse E, Habermann G, Osterburg I, Korte R, Weinbauer GF. 2003. Reproductive/developmental toxicity and immunotoxicity assessment in the nonhuman primate model. Toxicology 185:221-227.
10. Bussiere JL, Martin P, Horner M, Couch J, Flaherty M, Andrews L, Beyer J, Horvath C. 2009. Alternative strategies for toxicity testing of species-specific biopharmaceuticals. Int J Toxicol 28:230-253.
11. Cavagnaro JA. 2008. The principles of ICH S6 and the case-by-case approach. In: Cavagnaro JA, editor. Preclinical safety evaluation of biopharmaceuticals. Hoboken, NJ: John Wiley & Sons, Inc. p 45-65.
12. Chapman K, Pullen N, Graham M, Ragan I. 2007. Preclinical safety testing of monoclonal antibodies: the significance of species relevance. Nat Rev Drug Discov 6:120-126.
13. Chapman K, Pullen N, Coney L, Dempster M, Andrews L, Bajramovic J, Baldrick P, Buckley L, Jacobs A, Hale G, Green C, Ragan I, Robinson V. 2009. Preclinical development ofmonoclonal antibodies: considerations for the use of non-human primates. mAbs 1:505-516.
14. Coe CL, Kemnitz JW, Schneider ML. 1993. Vulnerability of placental antibody transfer and fetal complement synthesis to disturbance of the pregnant monkey. J Med Primatol 22:294-300.
15. Cole MF, Bowen WH. 1976. Immunoglobulins A, G, and M in serum and in some secretions of monkeys (Macaca fascicularis syn. irus). Infect Immun 13:1354-1359.
16. Dancis J, Lind J, Oratz M, Smolens J, Vara P. 1961. Placental transfer of proteins in human gestation. Am J Obstet Gynecol 82:167-171.
17. de Rijk EPCT, Van Esch E. 2008. The macaque placenta: a mini-review. Toxicol Pathol 36:108S-118S.
18. Dreef HC, Van Esch E, De Rijk EP. 2007. Spermatogenesis in the cynomolgus monkey (Macaca fascicularis): a practical guide for routine morphological staging. Toxicol Pathol 35:395-404.
19. Food and Drug Administration. 2006. Guidance for Industry: Nonclinical safety evaluation of pediatric drug products. Silver Spring, MD: U.S. Department of Health and Human Services, Center for Drug Evaluation and Research.
20. Foppiani L, Schlatt S, Simoni M, Weinbauer GF, Hacker-Klom U, Nieschlag E. 1999. Inhibin B is a more sensitive marker of spermatogenetic damage than FSH in the irradiated non-human primate model. J Endocrinol 162:393-400.
21. Fuchs A, Weinbauer GF. 2006. Feasibility of embryofetal development studies in the marmoset (Callithrix jacchus). In: Weinbauer G, Vogel F, editors. Novel approaches toward primate toxicology. Münster: Waxmann Verlag GmbH. p 110-122.
22. Fujimoto K, Terao K, Cho F, Honjo S. 1983. The placental transfer of IgG in the cynomolgus monkey. Jpn J Med Sci Biol 36:171-176.
23. Golub MS, Sassenrath EN, Chapman LF. 1981. Mother-infant interaction in rhesus monkeys treated clinically with delta-9-tetrahydrocannabinol. Child Dev 52:389-392.
24. Golub MS, Gershwin ME, Hurley LS, Hendrickx AG, Saito WY. 1985. Studies of marginal zinc deprivation in rhesus monkeys: infant behavior. Am J Clin Nutr 42:1229-1239.
25. Gribnau AA, Geijsberts LG. 1981. Developmental stages in the rhesus monkey (Macaca mulatta). Adv Anat Embryol Cell Biol 68:1-84.
26. Gribnau AA, Geijsberts LG. 1985. Morphogenesis of the brain in staged rhesus monkey embryos. Adv Anat Embryol Cell Biol 91:1-69.
27. Harlow H. 1959. The development of learning in the rhesus monkey. Am Sci 45:459-479.
28. Henck JW, Hilbish KG, Serabian MA, Cavagnaro JA, Hendrickx AG, Agnish ND, Kung AH, Mordenti J. 1996. Reproductive toxicity testing of therapeutic biotechnology agents. Teratology 53:185-195.
29. Hendrickx AG, Cukierski MA. 1987. Reproductive and developmental toxicology in nonhuman primates. Prog Clin Biol Res 235:73-88.
30. Hendrickx AG, Dukelow WR. 2005. Reproductive biology. In: Bennett BT, Abee CR, Henrickson R, editors. Nonhuman primates in biomedical research biology and management. New York: Academic Press. p 147-191.
31. Hendrickx AG, Peterson PE, Makori NM. 2005. The nonhuman primate as a model of developmental immunotoxicity. In: Holladay SD, editor. Developmental immuntoxicology. Boca Raton: CRC Press LLC. p 117-136.
32. Hendrie TA, Peterson PE, Short JJ, Tarantal AF, Rothgarn E, Hendrie MI, Hendrickx AG. 1996. Frequency of prenatal loss in a macaque breeding colony. Am J Primatol 40:41-53.
33. Holsapple MP, West LJ, Landreth KS. 2003. Species comparison of anatomical and functional immune system development. Birth Defects Res B 68:321-334.
34. ICH M3 (R2): Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals: Step 4, June 2009. www.ich.org.
35. ICH S5 (R2): Guidance on reproductive toxicology and male fertility: detection of toxicity to reproduction for medicinal products. 2005. www.ich.org.
36. ICH S6: Preclinical safety evaluation of biotechnology-derived pharmaceuticals. 1997. www.ich.org.
37. ICH S6 (R1): Addendum to ICH S6: preclinical safety evaluation of biotechnology-derived pharmaceuticals. Step 2, October 2009. www.ich.org.
38. Jauniaux E, Gulbis B. 2000. In vivo investigation of placental transfer early in human pregnancy. Eur J Obstet Gynecol Reprod Biol 92:45-49.
39. Jarvis P, Srivastav S, Vogelwedde E, Stewart J, Mitchard M, Weinbauer GF. The cynomolgus monkey as a model for developmental toxicity studies: variability of pregnancy losses, statistical power estimates and group size considerations (manuscript in preparation; abstract presented at European Teratology Society Meeting, 2009).
40. Leach JL, Sedmak DD, Osborne JM, Rahill B, Lairmore MD, Anderson CL. 1996. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J Immunol 157:3317-3322.
41. Maestripieri D, Jovanovic T, Gouzoules H. 2000. Crying and infant abuse in rhesus monkeys. Child Dev 71:301-309.
42. Makori N, Rodriguez CG, Cukierski MA, Hendrickx AG. 1996. Development of the brain in staged embryos of the long-tailed monkey (Macaca fascicularis). Primates 37:351-361.
43. Makori N, Tarantal AF, Lü FX, Rourke T, Marthas ML, McChesney MB, Hendrickx AG, Miller CJ. 2003. Functional and morphological development of lymphoid tissues and immune regulatory and ef fector function in rhesus monkeys: cytokine-secreting cells, immunoglobulin-secreting cells, and CD5(1) B-1 cells appear early in fetal development. Clin Diagn Lab Immunol 10:140-153.
44. Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H. 1996. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 36:248-255.
45. Martin PL. 2008. Reproductive toxicity testing for biopharmaceuticals. In: Cavagnaro JA, editor. Preclinical safety evaluation of biopharmaceuticals. Hoboken, NJ: John Wiley & Sons, Inc. p 357-377.
46. Martin PL, Buse E. 2008. Developmental immunotoxicity in nonhuman primates. In: Hertzyk DJ, Bussiere JL, editors. Immunotoxicology strategies for pharmaceutical safety assessment. Hoboken, NJ: John Wiley & Sons, Inc. p 299-317.
47. Martin PL, Oneda S, Treacy G. 2007. Ef fects of an anti-TNF-alpha monoclonal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system. Am J Reprod Immunol 58:138-149.
48. Martin PL, Breslin W, Rocca M, Wright D, Cavagnaro J. 2009. Considerations in assessing the developmental and reproductive toxicity potential of biopharmaceuticals. Birth Defects Res B 86:176-203.
49. Meyer JK, Fitzsimmons D, Hastings TF, Chellman GJ. 2006. Methods for the prediction of breeding success in male cynomolgus monkeys (Macaca fascicularis) used for reproductive toxicology studies. J Am Assoc Lab Anim Sci 45:31-36.
50. Niehoff MO, Bergmann M,Weinbauer GF. 2009. Ef fects of social housing of sexually mature male cynomolgus monkeys during general and reproductive toxicity evaluation. Reprod Toxicol E-publication 04 Oct 2009.
51. Palfi M, Selbring A. 1998. Placental transport of maternal immunoglobulin G. Am J Reprod Immunol 39:24-26.
52. Pentšuk N, van der Laan JW. 2009. An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies. Birth Defects Res B 86:328-344.
53. Peterson PE, Short JJ, Tarara R, Valverde C, Rothgarn E, Hendrickx AG. 1997. Frequency of spontaneous congenital defects in rhesus and cynomolgus macaques. J Med Primatol 26:267-275.
54. Plant TM. 1981. Time courses of concentrations of circulating gonadotropin, prolactin, testosterone, and cortisol in adult male rhesus monkeys (Macaca mulatta) throughout the 24 h light-dark cycle. Biol Reprod 25:244-252.
55. Ponce R, Abad L, Amaravadi L, Gelzleichter T, Gore E, Green J, Gupta S, Herzyk D, Hurst C, Ivens IA, Kawabata T, Maier C, Mounho B, Rup B, Shankar G, Smith H, Thomas P, Wierda D. 2009. Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies. Regul Toxicol Pharmacol 54:164-182.
56. Rasmussen AD, Nelson JK, Chellman GJ, Golub M, McAnulty PA. 2007. Use of barusiban in a novel study design for evaluation of tocolytic agents in pregnant and neonatal monkeys, including behavioural and immunological endpoints. Reprod Toxicol 23:471-479.
57. Robinson K, Varela A, Doyle N, Jolette J, Luc C, Sabourin M, Chevrier C, Smith SY. 2004. Feasibility study to assess skeletal development in non-clinical pediatric studies. Toxicologist 78:432-433.
58. Roopenian DC, Akilesh S. 2007. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 7:715-725.
59. Schardein JL, Schwetz BA, Kenel MF. 1985. Species sensitivities and prediction of teratogenic potential. Environ Health Perspect 61:55-67.
60. Shankar G, Pendley C, Stein KE. 2007. A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs. Nat Biotechnol 25:555-561.
61. Simister NE. 1998. Human placental Fc receptors and the trapping of immune complexes. Vaccine 16:1451-1455.
62. Simister NE. 2003. Placental transport of immunoglobulin G. Vaccine 21:3365-3369.
63. Stewart J. 2009. Developmental toxicity testing of monoclonal antibodies: An enhanced pre- and postnatal study design option. Reprod Toxicol 28:220-225.
64. Subramanyam M, Rinaldo N, Mertsching E, Hutto D. 2008. Selection of relevant species. In: Cavagnaro JA, editor. Preclinical safety evaluation of biopharmaceuticals. Hoboken, NJ: John Wiley & Sons, Inc. p 181-206.
65. Tarantal AF, Hendrickx AG. 1988a. Characterization of prenatal growth and development in the crab-eating macaque (Macaca fascicularis) by ultrasound. Anat Rec 222:177-184.
66. Tarantal AF, Hendrickx AG. 1988b. Prenatal growth in the cynomolgus and rhesus macaque (Macaca fascicularis and Macaca mulatta): a comparison by ultrasonography. Am J Prim 15:309-323.
67. Tsuchida J, Kawasaki K, Sankai T, Kubo N, Terao K, Koyama T, Makino J, Yoshikawa Y. 2003. New type of puzzle-task finger maze learning in Macaca fascicularis. Int J Primatol 24:261-270.
68. Van de Perre P. 2003. Transfer of antibody via mother's milk. Vaccine 21:3374-3376.
69. Van Esch E, Cline M, Buse E, Wood CE, de Rijk EPCT, Weinbauer GF. 2008. Summary comparison of female reproductive system in human and the cynomolgus monkey (Macaca fascicularis). Toxicol Pathol 36:171S-172S.
70. Vogel F, Bee W. 1999. Reproductive toxicology in primates: an overview of methods and techniques. In: Weinbauer GF, Korte R, editors. Reproduction in nonhuman primates. Münster: Waxmann Verlag GmbH. p 95-110.
71. Walthall K, Cappon GD, Hurtt ME, Zoetis T. 2005. Postnatal development of the gastrointestinal system: a species comparison. Birth Defects Res B 74:132-156.
72. Weinbauer GF. 2002. The non-human primate as a model in developmental and reproductive toxicity. In: Korte R, Weinbauer GF, editors. Primate models in pharmaceutical drug development. Münster: Waxmann Verlag GmbH. p 49-66.
73. Weinbauer GF, Niehoff M, Niehaus M, Srivastav S, Fuchs A, Van Esch E, Cline JM. 2008a. Physiology and endocrinology of the ovarian cycle in macaques. Toxicol Pathol 36:7S-23S.
74. Weinbauer GF, Frings W, Fuchs A, Osterburg I. 2008b. Reproductive/ developmental toxicity assessment of biopharmaceuticals in nonhuman primates. In: Cavagnaro JA, editor. Preclinical safety evaluation of biopharmaceuticals. A science-based approach to facilitating clinical trials. Hoboken, NJ: John Wiley & Sons, Inc. p 379-397.
75. Wen X-H, Yang Z-W. 2000. Quantitative (stereological) study on the spermatozoal storage capacity of epididymis in rats and monkeys. Asian J Androl 2:73-77.
76. Wickings EJ, Nieschlag E. 1980. Seasonality in endocrine and exocrine testicular function of the adult rhesus monkey (Macaca mulatta) maintained in a controlled laboratory environment. Int J Androl 3:87-104.
77. Wood SL, Beyer BK, Cappon GD. 2003. Species comparison of postnatal CNS development: functional measures. Birth Defects Res B 68:391-407.
78. Zoetis T, Hurtt ME. 2003a. Species comparison of anatomical and functional renal development. Birth Defects Res B 68:111-120.
79. Zoetis T, Hurtt ME. 2003b. Species comparison of lung development. Birth Defects Res B 68:121-124.
80. Zoetis T, Tassinari MS, Bagi C, Walthall K, Hurtt ME. 2003. Species comparison of postnatal bone growth and development. Birth Defects Res B 68:86-110.
81. Zuhlke U, Weinbauer GF. 2003. The common marmoset (Callithrix jacchus) as a model in toxicology. Toxicol Pathol 31:123-127.